DOAC failure due to PPI interaction Doctors are warning clinicians to watch for potential, previously unreported DOAC interactions with PPIs following a case report of sub therapeutic anticoagulation with dabigatran. The latest case, published in a letter to the editor of Internal Medicine Journal, describes an 81-year old male patient on dabigatran for AF. He ...
News in Brief: DOAC interaction with PPI; COVID-19 vaccine for haemophilia patients; Billion dollar fine for clopidogrel claims
18 Feb 2021